BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6134572)

  • 1. Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity.
    Gordon JH; Perry KO
    Brain Res Bull; 1983 Apr; 10(4):425-8. PubMed ID: 6134572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypophysectomy-induced striatal hypersensitivity and mesolimbic hyposensitivity to apomorphine.
    Gordon JH
    Pharmacol Biochem Behav; 1983 Nov; 19(5):807-11. PubMed ID: 6139829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible role of 2-hydroxyestradiol in the development of estrogen-induced striatal dopamine receptor hypersensitivity.
    Clopton JK; Gordon JH
    Brain Res; 1985 Apr; 333(1):1-10. PubMed ID: 2986765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogen.
    Perry KO; Diamond BI; Fields JZ; Gordon JH
    Brain Res; 1981 Dec; 226(1-2):211-9. PubMed ID: 7197571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estradiol on intact and denervated striatal dopamine receptors and on dopamine levels: a biochemical and behavioral study.
    Di Paolo T; Bédard PJ; Dupont A; Poyet P; Labrie F
    Can J Physiol Pharmacol; 1982 Mar; 60(3):350-7. PubMed ID: 7200388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal synaptosomal tyrosine hydroxylase activity. A model system for study of presynaptic dopamine receptors.
    McMillen BA
    Biochem Pharmacol; 1982 Aug; 31(16):2643-7. PubMed ID: 6128002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum.
    Hruska RE; Silbergeld EK
    Eur J Pharmacol; 1980 Feb; 61(4):397-400. PubMed ID: 7189464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA; Kuczenski R
    Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
    Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
    Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of potentiation of apomorphine-induced stereotypy due to electroconvulsive shock.
    Gulati A; Srimal RC; Dhawan KN; Dhawan BN
    Neuropharmacology; 1987 Dec; 26(12):1733-7. PubMed ID: 3437939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Estrogen on Striatal Dopamine receptor function in male and female rats.
    Hruska RE; Ludmer LM; Pitman KT; De Ryck M; Silbergeld EK
    Pharmacol Biochem Behav; 1982 Feb; 16(2):285-91. PubMed ID: 7200238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum.
    Klug JM; Norman AB
    Pharmacol Biochem Behav; 1993 Oct; 46(2):397-403. PubMed ID: 7903458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine-induced changes in striatal dopamine mechanisms not evoked from the dopamine nerve terminals.
    Andén NE; Grabowska-Andén M
    J Pharm Pharmacol; 1978 Nov; 30(11):732-4. PubMed ID: 31444
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of apomorphine-induced stereotypy by estrogen: time course and dose response.
    Gordon JH
    Brain Res Bull; 1980; 5(6):679-82. PubMed ID: 7193504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
    Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
    Kikuchi T; Tottori K; Uwahodo Y; Hirose T; Miwa T; Oshiro Y; Morita S
    J Pharmacol Exp Ther; 1995 Jul; 274(1):329-36. PubMed ID: 7616416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.